GGrantIndex
Sort

141,003 grants matching cytokine

Variation in Human Innate Immunity

$889,343
Thomas R Martin · University Of Washington · U54 · FY2008 · AI

Observation Study of Persons with Chronic Hepatitis B Virus infection in North America

$889,332
Harry Janssen · University Health Network · U01 · FY2016 · DK

Mechanisms of Secondary Damage After Spinal Cord Injury

$889,321
Jacqueline C Bresnahan · University Of California, San Francisco · R01 · FY2010 · NS

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection

$889,289
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Immune Correlates of Protection from TB

$889,259
Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2022 · AI

Next Generation Cancer Immunotherapies to Defeat Melanoma

$889,199
Antoni Ribas · University Of California Los Angeles · R35 · FY2024 · CA

Neuroprotective And Neurorestorative Signaling Mechanisms

$889,154
Mark Mattson · National Institute On Aging · ZIA · FY2015 · AG

DNA Vaccine for Induction of Mucosal Immunity

$889,109
David B. Weiner · University Of Pennsylvania · P01 · FY2011 · AI

Characterization And Functional Significance Of P450 Arachidonate Epoxygenases

$889,054
Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES

Diagnostic and Prognostic Biomarkers for Viral Severe Lung Disease

$889,034
Ralph S Baric · Columbia University Health Sciences · U19 · FY2016 · AI

Pre-Clinical Safety and Efficacy of TRB-N0224 for the Treatment of Periodontal Disease

$888,810
Lorne M Golub · Traverse Biosciences, Inc. · R42 · FY2016 · DE

Virus Clearance from the Central Nervous System

$888,709
Douglas Craig Hooper · Thomas Jefferson University · R01 · FY2013 · AI

Function of granulysin

$888,707
Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Regulatory T cells maintain immune homeostasis through translation control

$888,447
Steven F Ziegler · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · AI

The functional significance of CTL escape

$888,436
David I Watkins · George Washington University · R01 · FY2022 · AI

Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids

$888,324
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2023 · DA

New NAPRTCS Trials in Steroid-Free Immunosuppression

$888,275
Stanford University · U01 · FY2003 · AI

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

$887,976
William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2020 · CA

Vitamin D and Gut Microbiota and Dementia Risk in Older Adults with Chronic HIV infection and Demographically Matched Community Controls

$887,772
Amara E Ezeamama · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2024 · AG

Mechanisms of sphingolipid signaling in vascular health and disease

$887,736
Timothy Tun Hla · Boston Children'S Hospital · R35 · FY2023 · HL

Genomics and Proteomics of Head and Neck Cancer

$887,719
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2010 · DC

Substance Use and Immunity in HIV+ Adolescents by Systems Biology

$887,560
Maureen M Goodenow · University Of Florida · R01 · FY2012 · DA

Cell-free assay technologies for the identification of active compounds

$887,458
Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome

$887,354
Michaela Christina Kollisch-Singule · Cmtx Biotech, Inc. · R42 · FY2025 · HL

Nuclear Factor-kappaB in Ovarian Cancer

$887,215
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA